U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
RESIMMUNE
P7MQ9ZOQ82
Investigational
General
Record Details
Names
5
Classification
1
Identifiers
3
Concept Definition
Relationships
1
Active Moiety
1
RESIMMUNE
P7MQ9ZOQ82
Investigational
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Concept
Record UNII
P7MQ9ZOQ82
Record Status
Validated (UNII)
Record Version
12
11
10
9
8
7
6
5
4
3
2
1
Names
5
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
RESIMMUNE
Brand Name
English
A-DMDT390-BISFV(UCHT1)
Common Name
English
RECOMBINANT ANTI-CDR-BI-SINGLE-CHAIN-FV-DIPHTHERIA TOXIN FUSION PROTEIN
Common Name
English
ANTI-CD3 IMMUNOTOXIN A-DMDT390-BISFV(UCHT1)
Common Name
English
LAX-699
Code
English
Showing 1 to 5 of 5 entries
Previous
1
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of cutaneous T-cell lymphoma
FDA ORPHAN DRUG
448114
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
3
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
1470038-56-2
PRIMARY
FDA UNII
P7MQ9ZOQ82
PRIMARY
NCI_THESAURUS
C74004
PRIMARY
NCIT
Showing 1 to 3 of 3 entries
Previous
1
Next
Concept Definition
This is a non-substance concept
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
ZLW14X2D30
CD3
TARGET->CONJUGATED TOXIN
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
P7MQ9ZOQ82
RESIMMUNE
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
This is a non-substance concept
